165 related articles for article (PubMed ID: 35848898)
1. Clinical significance and immune landscape of KIR2DL4 and the senescence-based signature in cutaneous melanoma.
Mao R; Ren Z; Yang F; Yang P; Zhang T
Cancer Sci; 2022 Nov; 113(11):3947-3959. PubMed ID: 35848898
[TBL] [Abstract][Full Text] [Related]
2. Leveraging a cuproptosis-based signature to predict the prognosis and drug sensitivity of cutaneous melanoma.
Liu D; Yang F; Zhang T; Mao R
J Transl Med; 2023 Jan; 21(1):57. PubMed ID: 36717900
[TBL] [Abstract][Full Text] [Related]
3. Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab.
Zheng G; Guo Z; Li W; Xi W; Zuo B; Zhang R; Wen W; Yang AG; Jia L
Signal Transduct Target Ther; 2021 Jun; 6(1):236. PubMed ID: 34158475
[TBL] [Abstract][Full Text] [Related]
4. Identification of immune-related genes with prognostic significance in the microenvironment of cutaneous melanoma.
Qu Y; Zhang S; Zhang Y; Feng X; Wang F
Virchows Arch; 2021 May; 478(5):943-959. PubMed ID: 33179141
[TBL] [Abstract][Full Text] [Related]
5. Roles of HLA-G/KIR2DL4 in Breast Cancer Immune Microenvironment.
Zheng G; Jia L; Yang AG
Front Immunol; 2022; 13():791975. PubMed ID: 35185887
[TBL] [Abstract][Full Text] [Related]
6. The genotype of the NK cell receptor, KIR2DL4, influences INFgamma secretion by decidual natural killer cells.
Goodridge JP; Lathbury LJ; John E; Charles AK; Christiansen FT; Witt CS
Mol Hum Reprod; 2009 Aug; 15(8):489-97. PubMed ID: 19509110
[TBL] [Abstract][Full Text] [Related]
7. A Four-Cell-Senescence-Regulator-Gene Prognostic Index Verified by Genome-Wide CRISPR Can Depict the Tumor Microenvironment and Guide Clinical Treatment of Bladder Cancer.
Sun JX; Liu CQ; Xu JZ; An Y; Xu MY; Zhong XY; Zeng N; Ma SY; He HD; Zhang ZB; Wang SG; Xia QD
Front Immunol; 2022; 13():908068. PubMed ID: 35898492
[TBL] [Abstract][Full Text] [Related]
8. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
[TBL] [Abstract][Full Text] [Related]
9. Construction of Circadian Clock Signature for Tumor Microenvironment in Predicting Survival for Cutaneous Melanoma.
Zeng N; Xia Q; Li Y; Ma L; Cheng Y; Chen Y; Lu Q; Lu Z; Wu D; Luo D
Curr Pharm Des; 2022; 28(28):2349-2361. PubMed ID: 35927923
[TBL] [Abstract][Full Text] [Related]
10. Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer.
Wan R; Wang ZW; Li H; Peng XD; Liu GY; Ou JM; Cheng AQ
Cell Physiol Biochem; 2017; 44(5):1828-1841. PubMed ID: 29224003
[TBL] [Abstract][Full Text] [Related]
11. Identification of immune-related genes and integrated analysis of immune-cell infiltration in melanoma.
He Z; Chen M; Luo Z
Aging (Albany NY); 2024 Jan; 16(1):911-927. PubMed ID: 38217549
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
Tian Q; Gao H; Zhao W; Zhou Y; Yang J
Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
[TBL] [Abstract][Full Text] [Related]
13. [Immune Microenvironment Comparation Study between EGFR Mutant and EGFR Wild Type Lung Adenocarcinoma Patients Based on TCGA Database].
Zhu G; Li Y; Shi R; Xu S; Zhang Z; Cao P; Chen C; Liu H; Chen J
Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):236-244. PubMed ID: 33910272
[TBL] [Abstract][Full Text] [Related]
14. Landscape and Clinical Significance of Immune Checkpoint in Cutaneous Melanoma.
Mao R; Yang F; Zhang T; Li J
Front Immunol; 2021; 12():756282. PubMed ID: 35003069
[TBL] [Abstract][Full Text] [Related]
15. Core immune cell infiltration signatures identify molecular subtypes and promote precise checkpoint immunotherapy in cutaneous melanoma.
Zhu Z; Li G; Li Z; Wu Y; Yang Y; Wang M; Zhang H; Qu H; Song Z; He Y
Front Immunol; 2022; 13():914612. PubMed ID: 36072600
[TBL] [Abstract][Full Text] [Related]
16. A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients.
Cursons J; Souza-Fonseca-Guimaraes F; Foroutan M; Anderson A; Hollande F; Hediyeh-Zadeh S; Behren A; Huntington ND; Davis MJ
Cancer Immunol Res; 2019 Jul; 7(7):1162-1174. PubMed ID: 31088844
[TBL] [Abstract][Full Text] [Related]
17. The effects of KIR2DL4 stimulated NK-92 cells on the apoptotic pathways of HER2 + /HER-breast cancer cells.
Kilic N; Dastouri M; Kandemir I; Yilmaz E
Med Oncol; 2023 Apr; 40(5):139. PubMed ID: 37027073
[TBL] [Abstract][Full Text] [Related]
18. Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.
Xu X; Li J; Zou J; Feng X; Zhang C; Zheng R; Duanmu W; Saha-Mandal A; Ming Z; Wang E
JAMA Netw Open; 2019 Sep; 2(9):e199292. PubMed ID: 31483464
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide siRNA screen reveals a new cellular partner of NK cell receptor KIR2DL4: heparan sulfate directly modulates KIR2DL4-mediated responses.
Brusilovsky M; Cordoba M; Rosental B; Hershkovitz O; Andrake MD; Pecherskaya A; Einarson MB; Zhou Y; Braiman A; Campbell KS; Porgador A
J Immunol; 2013 Nov; 191(10):5256-67. PubMed ID: 24127555
[TBL] [Abstract][Full Text] [Related]
20. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma.
Xu Y; Chen Y; Niu Z; Yang Z; Xing J; Yin X; Guo L; Zhang Q; Yang Y; Han Y
Front Surg; 2022; 9():860806. PubMed ID: 35937602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
